Key result
Local conduction delay induced by sodium channel blockers linearly correlated with a decrease in high-frequency QRS components (r=0.75 to 0.83, p<0.001).
Why the study?
Does local conduction delay induced by antiarrhythmic drugs decrease the high frequency QRS components in a canine model?
Does local conduction delay induced by antiarrhythmic drugs decrease the high frequency QRS components in a canine model?
This preclinical study demonstrates that local conduction delay linearly decreases high frequency QRS components, suggesting HF-QRS is a potent indicator of disturbed local conduction.
Answers are grounded in this paper and cite their sources.
HF-QRS reduction tracks conduction delay in canine models; leaves open diagnostic translation to human conduction disease.
The high frequency components contained in the QRS complex (HF-QRS) are a powerful indicator for the risk of sudden cardiac death. However, it is controversial whether conduction delay increases or decreases the HF-QRS. In 21 anesthetized, open-chest dogs, the right atrium was constantly paced. A cannula was inserted into the left anterior descending artery and flecainide, lidocaine or disopyramide was infused to slow the local conduction. Sixty unipolar electrograms were recorded from the entire ventricular surface and were signal-averaged. Data were filtered (30-250 Hz) by using fast-Fourier transform. The HF-QRS was calculated by integrating the filtered QRS signal. Activation time (AT; dV/dt minimum) was delayed and the HF-QRS was reduced in the area perfused by flecainide, lidocaine or disopyramide. The percent increase in AT closely correlated the percentage decrease in the HF-QRS; the correlation coefficients were 0.75, 0.83 and 0.76 for flecainide, lidocaine and disopyramide infusion, respectively, (p<0.001). Decrease in the HF-QRS linearly correlated with the local conduction delay. This study proved that conduction delay decreases the HF-QRS, and that the HF-QRS is a potent indicator of disturbed local conduction.
No takes yet. Share an insight, caveat, or question.
Watanabe et al. (1998) studied Local conduction delay (n=21). Sodium channel blockers (flecainide, lidocaine, or disopyramide) vs. Baseline (control) was evaluated on Correlation between percentage increase in activation time and percentage decrease in high-frequency QRS components (r=0.75 to 0.83, p=<0.001). Local conduction delay induced by sodium channel blockers linearly correlated with a decrease in high-frequency QRS components (r=0.75 to 0.83, p<0.001).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: